318 related articles for article (PubMed ID: 31023282)
1. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
2. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.
Li Y; Zhao Y; Wu J
PLoS One; 2017; 12(5):e0177713. PubMed ID: 28505202
[TBL] [Abstract][Full Text] [Related]
3. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis.
Jinjuvadia R; Patel S; Liangpunsakul S
J Clin Gastroenterol; 2014 Feb; 48(2):172-7. PubMed ID: 24402120
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis.
Wang J; Li J; Zhou Q; Zhang D; Bi Q; Wu Y; Huang W
Hepatol Commun; 2018 Apr; 2(4):467-476. PubMed ID: 29619424
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome relates to high risk in hepatocellular carcinoma: a meta-analysis.
Li Y; Shi J; Liu X; Deng Q; Huang Y; Yang Z
Discov Med; 2018 Nov; 26(144):185-196. PubMed ID: 30695678
[TBL] [Abstract][Full Text] [Related]
6. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Xia HM; Shen L; Zhang N
J Viral Hepat; 2009 Apr; 16(4):265-71. PubMed ID: 19220736
[TBL] [Abstract][Full Text] [Related]
7. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
8. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
Todowede OO; Mianda SZ; Sartorius B
Syst Rev; 2019 Jan; 8(1):4. PubMed ID: 30606249
[TBL] [Abstract][Full Text] [Related]
10. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R; Lohia P; Jinjuvadia C; Montoya S; Liangpunsakul S
J Clin Gastroenterol; 2013 Jan; 47(1):33-44. PubMed ID: 23090040
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies.
Chen Y; Li X; Wu S; Ye W; Lou L
Onco Targets Ther; 2018; 11():6277-6285. PubMed ID: 30310291
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
[TBL] [Abstract][Full Text] [Related]
13. On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis.
Wu S; Kong Y; Piao H; Jiang W; Xie W; Chen Y; Lu L; Ma A; Xie S; Ding H; Shang J; Zhang X; Feng B; Han T; Xu X; Huo L; Cheng J; Li H; Wu X; Zhou J; Sun Y; Ou X; Zhang H; You H; Jia J
Liver Int; 2018 Jun; 38(6):1045-1054. PubMed ID: 29119705
[TBL] [Abstract][Full Text] [Related]
14. Basal cortisol levels and metabolic syndrome: A systematic review and meta-analysis of observational studies.
Garcez A; Leite HM; Weiderpass E; Paniz VMV; Watte G; Canuto R; Olinto MTA
Psychoneuroendocrinology; 2018 Sep; 95():50-62. PubMed ID: 29800780
[TBL] [Abstract][Full Text] [Related]
15. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
Li L; Lan X
J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
[TBL] [Abstract][Full Text] [Related]
16. Association between anxiety and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies.
Tang F; Wang G; Lian Y
Psychoneuroendocrinology; 2017 Mar; 77():112-121. PubMed ID: 28027497
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in hematologic malignancies survivors: a meta-analysis.
Li C; Liu P; Liu L; Zhang X; Yang P; Sheng H; Bu L; Li H; Qu S
Med Oncol; 2015 Jan; 32(1):422. PubMed ID: 25471791
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome and chronic liver disease.
Rosselli M; Lotersztajn S; Vizzutti F; Arena U; Pinzani M; Marra F
Curr Pharm Des; 2014; 20(31):5010-24. PubMed ID: 24320032
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
